title: The management of cancer in the elderly: targeted therapies in oncology.
abstract: Cancer is universally considered a disease of ageing. Today the management of elderly cancer patients poses many specific problems and it should be revisited in the light of the most recent advances in both diagnosis and treatment of human malignancies. In particular, the potential use of novel therapeutic options, based on therapeutic agents raised against molecular targets (the so called targeted therapy), appears to be promising in this clinical settings especially in view of the limited side-effects. The mainstays of cancer treatment during the twentieth century were surgery, radiation and chemotherapy. However, surgery is not curative in metastatic disease, radiation and chemotherapy are limited by side effects because they can't discriminate between healthy and cancerous cells. When key molecular changes responsible for malignant transformation were identified (e.g. growth factors and their receptors), it was hoped that new targeted agents, by inhibiting cancer-specific pathways, would spare normal cells and thereby offer improved safety benefits and a higher therapeutic index over standard chemotherapeutics. The most common targeted therapies used in clinical practice, i.e. monoclonal antibodies and small molecules, are described.
authors.affiliation: Clinical Oncology, Department of Oncology, M. Ascoli Cancer Hospital Center, ARNAS-Civico, Palermo, Italy. usset.antonella@libero.it
authors.forename: Biagio
authors.initials: B
authors.lastname: Agostara
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Carruba
authors.forename: Antonella
authors.initials: A
authors.lastname: Usset